Budget impact model of adding erlotinib to a regimen of gemcitabine for the treatment of locally advanced, nonresectable or metastatic pancreatic cancer (Q46050381)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Budget impact model of adding erlotinib to a regimen of gemcitabine for the treatment of locally advanced, nonresectable or metastatic pancreatic cancer |
scientific article |
Statements
1 reference
Budget impact model of adding erlotinib to a regimen of gemcitabine for the treatment of locally advanced, nonresectable or metastatic pancreatic cancer (English)
1 reference
Mark D Danese
1 reference
Carolina Reyes
1 reference
Kelly Northridge
1 reference
Deborah Lubeck
1 reference
Chin-Yu Lin
1 reference
Paula O'Connor
1 reference
1 April 2008
1 reference
1 reference
30
1 reference
4
1 reference
775-784
1 reference